Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Dexmethylphenidate hydrochloride by Cingulate for Attention Deficit Hyperactivity Disorder (ADHD): Likelihood of Approval
Dexmethylphenidate hydrochloride is under clinical development by Cingulate and currently in Phase III for Attention Deficit Hyperactivity Disorder (ADHD). According...